By Luis Hernandez

By Brendon Wen

By Harrison Grubb

By Tara Bannow

By Beth Hawkins & Nicholas Perez

By Michelle Crouch

By Ike Swetlitz

By Tom Knowles

by Barbara Dellenback

By Richard Stradling

by Flynn Snyder

by Regan Butler

by Alex Olgin

by Alan Condon

by Lauren Clason

By Kate Rope

By Katie Palmer

by Sarah Kliff and Margot Sanger-Katz

by Chris Cumming

By Nick Budnick

by Shannon Firth

By Tara Bannow

by Nick Stonesifer

By Christopher Snowbeck

By Sarah Mueller

But are price controls the answer?

by Nick Budnick and Joanne Zuhl

by Michelle Crouch and Charlotte Ledger

By Cindy Krischer Goodman

By Michelle Marchante and Amanda Rosa

By Jonny Williams

By Corrie Pikul

By Andrew Ryan and Emily Shearer

by Shaanth Nanguneri

By Kristine de Leon

"New state laws tackle the burden of medical debt and the corporate take-over of medicine."

The trend toward investor ownership is part of a broader national shift in health-care consolidation, said Hayden Rooke-Ley, a senior fellow at Brown University’s School of Public Health. Over the last decade, large non-hospital retailers such as Amazon and Walgreens, along with insurance conglomerates, have restructured to own or manage medical practices, drug distributors and wholesalers.

On October 6, 2025, California Governor Gavin Newsom signed SB 351, aimed at limiting the involvement of private equity groups and hedge funds in health care practices.

A bipartisan group of lawmakers has introduced legislation to stop Medicare Advantage insurers from collecting billions in federal payments for veterans who primarily receive care through the VA. Sparked by a Wall Street Journal investigation—supported by data from Brown University researchers—the bill aims to close a loophole that enabled an estimated $44 billion in excess payments from 2018 to 2021.

Several states are adopting hospital price caps to curb rising healthcare costs, citing limited success from other reforms. Supporters see savings, while hospitals warn of revenue loss and service cuts. See what CAHPR's Roslyn Murray, Ph.D. has to say.

On Wednesday, the state House passed Senate Bill 951, the latest effort to expand Oregon’s prohibitions on corporate ownership in local care providers.

This news video features Dr. Andrew Ryan, Director of CAHPR, discussing his study on Rhode Island’s hospital affordability standards, which led to significant hospital price and premium reductions—saving $1,000 per fully insured member by 2022.

This article reports on a study by CAHPR researchers that found that Rhode Island’s 2010 hospital price growth cap significantly reduced hospital prices and lowered premiums for fully insured health plans by $1,000 per member annually by 2022. However, the policy had limited impact on the self-insured market due to federal ERISA regulations, and the resulting hospital revenue losses have raised concerns about financial sustainability and care quality.

A Nevada bill aims to cap hospital fees for the Public Employees’ Benefits Program to reduce costs, drawing on Oregon's model, which researcher Roslyn Murray of Brown University studied and found led to significant savings without shifting costs to private insurers.

This news article highlights the study led by Dr. Roslyn Murray on potential savings achieved by capping state employee health plans while discussing how rising health care costs are squeezing state dollars.

This article talks about the analysis conducted by CAHPR researchers who find that routine medical care costs four times more in New York’s outpatient hospital facilities than in doctor’s offices, largely due to added facility fees. Economist Christopher Whaley and other experts have long highlighted such pricing disparities, fueling legislative efforts like the proposed Fair Pricing Act to cap these costs.

Gloria Sachdev has spent years challenging high hospital prices in Indiana, successfully pushing for healthcare cost transparency and legislative reforms. Her efforts, have led to a national report on hospital pricing and significant policy changes in the state.

This article covers a Brown University study, published in Health Affairs, which found that the Colorado Option lowered average marketplace premiums by $101 per month since 2020, while exchange premiums nationally rose by 10%.

This article covers criticisms from Colorado’s Health Care Future, which argues that the program has failed to lower premiums, harmed competition, and reduced consumer choices, while the state cites a Brown University analysis showing it provides affordable coverage and limits premium increases driven by rising hospital and provider costs.

This article talks about two conflicting studies on the Colorado Option emerged—one, funded by the insurance industry, found only 2% of plans met the 10% premium reduction goal, while another, by Brown University researchers and backed by the Commonwealth Fund, highlighted it as a model, estimating $100 lower premiums than similar states without a public option.